PROVENGE® (sipuleucel-T) Now FDA Approved
On April 29, 2010, the U.S. Food and Drug Administration approved PROVENGE for the treatment of men with asymptomatic or minimally symptomatic metastatic, castrate resistant (hormone refractory) prostate cancer...
PROVENGE Full Prescribing Information
Important Safety Information
NEWS & EVENTS
July 28, 2010
July 12, 2010
August 03, 2010
With every step of this journey, patients have been our inspiration...
INVESTORS
Dendreon is making news in the investment community. Click here to view our stock price, webcasts, and more.
CAREERS
Our innovation well beyond our science. Click here to explore job openings, company culture and more.